nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Allelotype and loss of heterozygosity around the L-myc gene locus in primary lung cancers
|
Mendoza, Ciro |
|
2000 |
28 |
2 |
p. 117-125 9 p. |
artikel |
2 |
An estimate of the cost of conducting phase II trials in lung cancer
|
Evans, William K. |
|
2000 |
28 |
2 |
p. 85-95 11 p. |
artikel |
3 |
A phase II trial of the combination of gemcitabine, ifosfamide and cisplatin in the treatment of advanced non-small cell lung cancer
|
Vadell-Nadal, C |
|
2000 |
28 |
2 |
p. 109-115 7 p. |
artikel |
4 |
A randomized phase II trial of two schedules of topotecan for the treatment of advanced stage non-small cell lung cancer
|
Weitz, John J |
|
2000 |
28 |
2 |
p. 157-162 6 p. |
artikel |
5 |
Cellular immunologic parameters related to age, gender, and stage in lung cancer patients
|
Nakamura, Haruhiko |
|
2000 |
28 |
2 |
p. 139-145 7 p. |
artikel |
6 |
Economic evaluation in a randomized phase III clinical trial comparing gemcitabine/cisplatin and etoposide/cisplatin in non-small cell lung cancer
|
Sacristán, José A |
|
2000 |
28 |
2 |
p. 97-107 11 p. |
artikel |
7 |
Endobronchial metastases secondary to solid tumors: report of eight cases and review of the literature
|
Katsimbri, Pelagia P. |
|
2000 |
28 |
2 |
p. 163-170 8 p. |
artikel |
8 |
Lung cancer risk in relation to genetic polymorphisms of microsomal epoxide hydrolase among African-Americans and Caucasians in Los Angeles County
|
London, Stephanie J. |
|
2000 |
28 |
2 |
p. 147-155 9 p. |
artikel |
9 |
RARβ2 specificity in mediating RA inhibition of growth of lung cancer-derived cells
|
Toulouse, André |
|
2000 |
28 |
2 |
p. 127-137 11 p. |
artikel |